Index by author
C
Castro, Mario
- You have accessBronchial thermoplasty: A new treatment for severe refractory asthmaThomas R. Gildea, MD, MS, Sumita B. Khatri, MD, MS and Mario Castro, MD, MPHCleveland Clinic Journal of Medicine July 2011, 78 (7) 477-485; DOI: https://doi.org/10.3949/ccjm.78a.10185
Asthma has a new treatment, but it isn’t for everybody. Here, we review its indications, evidence of efficacy, and protocols.
G
Gildea, Thomas R.
- You have accessBronchial thermoplasty: A new treatment for severe refractory asthmaThomas R. Gildea, MD, MS, Sumita B. Khatri, MD, MS and Mario Castro, MD, MPHCleveland Clinic Journal of Medicine July 2011, 78 (7) 477-485; DOI: https://doi.org/10.3949/ccjm.78a.10185
Asthma has a new treatment, but it isn’t for everybody. Here, we review its indications, evidence of efficacy, and protocols.
H
Hogarth, D. Kyle
- You have accessBronchial thermoplasty: A promising therapy, still in its infancyAmit K. Mahajan, MD and D. Kyle Hogarth, MD, FCCPCleveland Clinic Journal of Medicine July 2011, 78 (7) 475-476; DOI: https://doi.org/10.3949/ccjm.78a.11063
Inflammation is not the only pathophysiologic process underlying asthma. Bronchial thermoplasty takes a novel approach and offers reason for optimism.
I
Induru, Raghava R.
- You have accessManaging cancer pain: Frequently asked questionsRaghava R. Induru, MD and Ruth L. Lagman, MD, MPH, FACPCleveland Clinic Journal of Medicine July 2011, 78 (7) 449-464; DOI: https://doi.org/10.3949/ccjm.78a.10054
Cancer pain: its pathogenesis, how to assess it, and how to treat it—in particular, how to use opioids optimally.
J
Jaffer, Amir K.
- You have accessUpdate in hospital medicine: Studies likely to affect inpatient practice in 2011Amir K. Jaffer, MDCleveland Clinic Journal of Medicine July 2011, 78 (7) 430-434; DOI: https://doi.org/10.3949/ccjm.78gr.11002
A hypothetical case scenario helps focus on anticoagulants, patient safety, quality improvement, critical care, transitions of care, and perioperative medicine.
K
Khatri, Sumita B.
- You have accessBronchial thermoplasty: A new treatment for severe refractory asthmaThomas R. Gildea, MD, MS, Sumita B. Khatri, MD, MS and Mario Castro, MD, MPHCleveland Clinic Journal of Medicine July 2011, 78 (7) 477-485; DOI: https://doi.org/10.3949/ccjm.78a.10185
Asthma has a new treatment, but it isn’t for everybody. Here, we review its indications, evidence of efficacy, and protocols.
L
Lagman, Ruth L.
- You have accessManaging cancer pain: Frequently asked questionsRaghava R. Induru, MD and Ruth L. Lagman, MD, MPH, FACPCleveland Clinic Journal of Medicine July 2011, 78 (7) 449-464; DOI: https://doi.org/10.3949/ccjm.78a.10054
Cancer pain: its pathogenesis, how to assess it, and how to treat it—in particular, how to use opioids optimally.
M
Mahajan, Amit K.
- You have accessBronchial thermoplasty: A promising therapy, still in its infancyAmit K. Mahajan, MD and D. Kyle Hogarth, MD, FCCPCleveland Clinic Journal of Medicine July 2011, 78 (7) 475-476; DOI: https://doi.org/10.3949/ccjm.78a.11063
Inflammation is not the only pathophysiologic process underlying asthma. Bronchial thermoplasty takes a novel approach and offers reason for optimism.
Mandell, Brian F.
- You have accessWhen good drugs turn weirdly badBrian F. Mandell, MD, PhDCleveland Clinic Journal of Medicine July 2011, 78 (7) 426; DOI: https://doi.org/10.3949/ccjm.78b.11007
Even the most specific of drugs, such as interferon, can have untoward biologic effects.
Menon, Venu
- You have accessHypothermia after cardiac arrest: Beneficial, but slow to be adoptedSantosh Samuel Oommen, MD and Venu Menon, MDCleveland Clinic Journal of Medicine July 2011, 78 (7) 441-448; DOI: https://doi.org/10.3949/ccjm.78a.10157
Survivors of cardiac arrest due to ventricular tachycardia or ventricular fi brillation have better neurologic outcomes if they are cooled to a core body temperature of 32°C to 34°C for 24 hours as soon as possible after reaching the hospital.
N
Neuner, Elizabeth
- You have accessVancomycin: A 50-something-yearold antibiotic we still don’t understandAmy Schilling, PharmD, Elizabeth Neuner, PharmD and Susan J. Rehm, MDCleveland Clinic Journal of Medicine July 2011, 78 (7) 465-471; DOI: https://doi.org/10.3949/ccjm.78a.10168
To use vancomycin appropriately, we need to recognize its changing minimum inhibitory concentrations, select proper doses and dosing intervals, and know how to monitor its use.
O
Oommen, Santosh Samuel
- You have accessHypothermia after cardiac arrest: Beneficial, but slow to be adoptedSantosh Samuel Oommen, MD and Venu Menon, MDCleveland Clinic Journal of Medicine July 2011, 78 (7) 441-448; DOI: https://doi.org/10.3949/ccjm.78a.10157
Survivors of cardiac arrest due to ventricular tachycardia or ventricular fi brillation have better neurologic outcomes if they are cooled to a core body temperature of 32°C to 34°C for 24 hours as soon as possible after reaching the hospital.
R
Rehm, Susan J.
- You have accessVancomycin: A 50-something-yearold antibiotic we still don’t understandAmy Schilling, PharmD, Elizabeth Neuner, PharmD and Susan J. Rehm, MDCleveland Clinic Journal of Medicine July 2011, 78 (7) 465-471; DOI: https://doi.org/10.3949/ccjm.78a.10168
To use vancomycin appropriately, we need to recognize its changing minimum inhibitory concentrations, select proper doses and dosing intervals, and know how to monitor its use.
S
Schilling, Amy
- You have accessVancomycin: A 50-something-yearold antibiotic we still don’t understandAmy Schilling, PharmD, Elizabeth Neuner, PharmD and Susan J. Rehm, MDCleveland Clinic Journal of Medicine July 2011, 78 (7) 465-471; DOI: https://doi.org/10.3949/ccjm.78a.10168
To use vancomycin appropriately, we need to recognize its changing minimum inhibitory concentrations, select proper doses and dosing intervals, and know how to monitor its use.
T
Tang, Derek M.
- You have accessRash from hepatitis C treatmentDerek M. Tang, MD and Lawrence Ward, MD, MPHCleveland Clinic Journal of Medicine July 2011, 78 (7) 472-474; DOI: https://doi.org/10.3949/ccjm.78a.10124
Although the combination of interferon and ribavirin is the standard of treatment for chronic hepatitis C, some patients experience adverse reactions.
W
Ward, Lawrence
- You have accessRash from hepatitis C treatmentDerek M. Tang, MD and Lawrence Ward, MD, MPHCleveland Clinic Journal of Medicine July 2011, 78 (7) 472-474; DOI: https://doi.org/10.3949/ccjm.78a.10124
Although the combination of interferon and ribavirin is the standard of treatment for chronic hepatitis C, some patients experience adverse reactions.